Clopidogrel, Acetylsalicylic acid
Clopidogrel / Acetylsalicylic acid Viatris (previously Clopidogrel / Acetylsalicylic acid Mylan)
Indication
Clopidogrel/Acetylsalicylic acid Viatris is indicated for the secondary prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (ASA). Clopidogrel/Acetylsalicylic acid Viatris is a fixed-dose combination medicinal product for continuation of therapy in: - Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary intervention - ST segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.